
Michael Burgess, MD @michaelcburgess
17. H.R. 19 increases transparency into patent listings so that manufacturers of generics and biosimilars will have adequate information to enter the market. — PolitiTweet.org
Created
Thu Dec 12 17:23:04 +0000 2019
Likes
6
Retweets
0
Source
Twitter Web App
View Raw Data
JSON DataView on Twitter
Likely AvailableMichael Burgess, MD @michaelcburgess
17. H.R. 19 increases transparency into patent listings so that manufacturers of generics and biosimilars will have adequate information to enter the market. — PolitiTweet.org